Filing Details

Accession Number:
0001140361-24-050250
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-23 16:01:45
Reporting Period:
2024-12-19
Accepted Time:
2024-12-23 16:01:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Gyre Therapeutics Inc. GYRE Pharmaceutical Preparations (2834) 562020050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1985547 Songjiang Ma C/O Gyre Therapeutics, Inc.
12770 High Bluff Drive, Suite 150
San Diego CA 92130
President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-19 2,000 $10.82 2,936,467 No 4 S Indirect By Spouse
Common Stock Disposition 2024-12-20 2,000 $10.90 2,934,467 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Spouse
No 4 S Indirect By Spouse
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024.
  2. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.61 to $11.35. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.39 to $11.11. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.